Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 15147249)

Published in Headache on May 01, 2004

Authors

David Dodick1, Richard B Lipton, Vincent Martin, Vasilios Papademetriou, Wayne Rosamond, Antoinette MaassenVanDenBrink, Hassan Loutfi, K Michael Welch, Peter J Goadsby, Steven Hahn, Susan Hutchinson, David Matchar, Stephen Silberstein, Timothy R Smith, R Allan Purdy, Jane Saiers, Triptan Cardiovascular Safety Expert Panel

Author Affiliations

1: Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA.

Articles citing this

Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology (2009) 2.40

Migraine pathogenesis and state of pharmacological treatment options. BMC Med (2009) 1.16

Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14

Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am (2009) 1.04

Headache-type adverse effects of NO donors: vasodilation and beyond. Br J Pharmacol (2010) 0.88

Acute migraine: Current treatment and emerging therapies. Ther Clin Risk Manag (2007) 0.87

The pharmacological management of migraine, part 1: overview and abortive therapy. P T (2008) 0.84

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan. J Headache Pain (2008) 0.84

Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain (2015) 0.83

Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study. J Headache Pain (2015) 0.82

Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev (2017) 0.81

Rizatriptan in the treatment of migraine. Neuropsychiatr Dis Treat (2006) 0.81

Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. ACS Med Chem Lett (2010) 0.80

Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache. Patient Prefer Adherence (2012) 0.79

Migraine and risk of stroke in older adults: Northern Manhattan Study. Neurology (2015) 0.79

Headache management: pharmacological approaches. Pract Neurol (2015) 0.78

Migraine, cerebrovascular disease and the metabolic syndrome. Ann Indian Acad Neurol (2012) 0.77

Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug Des Devel Ther (2010) 0.77

[Current diagnosis and treatment of migraine]. Schmerz (2008) 0.76

The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects. Arch Drug Inf (2010) 0.76

Headache. Neurotherapeutics (2010) 0.75

Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog. Br J Pharmacol (2008) 0.75

Triptans and troponin: a case report. Orphanet J Rare Dis (2009) 0.75

Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis. Neural Regen Res (2013) 0.75

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk. Pain Res Treat (2016) 0.75

The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis. J Headache Pain (2017) 0.75

Current migraine management - patient acceptability and future approaches. Neuropsychiatr Dis Treat (2008) 0.75

Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review. Eur Arch Otorhinolaryngol (2017) 0.75

Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden. Eur J Clin Pharmacol (2016) 0.75

Adverse reactions related to drugs for headache treatment: clinical impact. Eur J Clin Pharmacol (2005) 0.75

Articles by these authors

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Migraine--current understanding and treatment. N Engl J Med (2002) 9.80

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Leisure activities and the risk of dementia in the elderly. N Engl J Med (2003) 8.77

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03

Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37

Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med (2006) 3.90

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA (2005) 3.89

Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA (2004) 3.88

Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med (2002) 3.88

Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proc Natl Acad Sci U S A (2008) 3.70

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation (2006) 3.69

Obesity and migraine: a population study. Neurology (2005) 3.67

Cognitive processes related to gait velocity: results from the Einstein Aging Study. Neuropsychology (2006) 3.34

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21

Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol (2006) 3.12

Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci (2009) 3.01

The positions of TFIIF and TFIIE in the RNA polymerase II transcription preinitiation complex. Nat Struct Mol Biol (2007) 3.00

An analysis of the spatial and temporal patterns of highly pathogenic avian influenza occurrence in Vietnam using national surveillance data. Vet J (2007) 2.94

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology (2008) 2.87

Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache (2005) 2.80

The typical duration of migraine aura: a systematic review. Cephalalgia (2013) 2.76

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache (2007) 2.75

Cutaneous allodynia in the migraine population. Ann Neurol (2008) 2.75

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol (2010) 2.70

High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA (2009) 2.70

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain (2008) 2.66

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation (2004) 2.56

Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) (2004) 2.45

Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 2.43

Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2012) 2.42

Anatidae migration in the western Palearctic and spread of highly pathogenic avian influenza H5NI virus. Emerg Infect Dis (2006) 2.40

Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc (2006) 2.35

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) (2004) 2.32

Cluster headache. BMJ (2012) 2.28

Two cyclin-dependent kinases promote RNA polymerase II transcription and formation of the scaffold complex. Mol Cell Biol (2004) 2.26

The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain (2005) 2.25

Numb chin syndrome. Headache (2008) 2.25

Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease. Circulation (2006) 2.20

The relationship between specific cognitive functions and falls in aging. Neuropsychology (2007) 2.17

Exercise capacity and mortality in black and white men. Circulation (2008) 2.17

Post-dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology. Headache (2010) 2.17

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia (2010) 2.17

A sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Headache (2012) 2.15

Mapping the location of TFIIB within the RNA polymerase II transcription preinitiation complex: a model for the structure of the PIC. Cell (2004) 2.15

Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens (2010) 2.14

BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia (2013) 2.14

A DNA-tethered cleavage probe reveals the path for promoter DNA in the yeast preinitiation complex. Nat Struct Mol Biol (2006) 2.13

Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci (2012) 2.12

A positron emission tomographic study in spontaneous migraine. Arch Neurol (2005) 2.12

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09

Predictors of unplanned readmission in patients undergoing lumbar decompression: multi-institutional analysis of 7016 patients. J Neurosurg Spine (2014) 2.09

Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study. J Womens Health (Larchmt) (2007) 2.08

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. Brain (2006) 2.08

Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia (2010) 2.07

Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens (2013) 2.03

Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02

Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet (2007) 2.02

Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc (2008) 2.00

Identification of TFB5, a new component of general transcription and DNA repair factor IIH. Nat Genet (2004) 1.99

Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ (2009) 1.98

Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98

Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache (2008) 1.95

Mechanisms of association between obesity and chronic pain in the elderly. Pain (2011) 1.94

Telephone screening for amnestic mild cognitive impairment. Neurology (2003) 1.93

Can patients with epilepsy predict their seizures? Neurology (2007) 1.90

Peripheral nerve blocks and trigger point injections in headache management - a systematic review and suggestions for future research. Headache (2010) 1.88

CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol (2010) 1.88

Binding of TFIIB to RNA polymerase II: Mapping the binding site for the TFIIB zinc ribbon domain within the preinitiation complex. Mol Cell (2003) 1.85

Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med (2004) 1.84

Posterior hypothalamic and brainstem activation in hemicrania continua. Headache (2004) 1.83

Excessive acute migraine medication use and migraine progression. Neurology (2008) 1.83

Phosphorylation of the transcription elongation factor Spt5 by yeast Bur1 kinase stimulates recruitment of the PAF complex. Mol Cell Biol (2009) 1.82

The epidemiology, burden, and comorbidities of migraine. Neurol Clin (2009) 1.81

Cluster headache: a prospective clinical study with diagnostic implications. Neurology (2002) 1.79

Modeling memory decline in older adults: the importance of preclinical dementia, attrition, and chronological age. Psychol Aging (2003) 1.79

Psychiatric comorbidity of migraine. Headache (2006) 1.77

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J (2013) 1.77

Reliability and validity of a telephone-based mobility assessment questionnaire. Age Ageing (2004) 1.77

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr (2007) 1.76

Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology (2013) 1.75

Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology (2004) 1.75

Chemical inhibition of the TFIIH-associated kinase Cdk7/Kin28 does not impair global mRNA synthesis. Proc Natl Acad Sci U S A (2007) 1.71

Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71

Migraine and autonomic nervous system function: a population-based, case-control study. Neurology (2002) 1.71

Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg (2010) 1.70

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens (2002) 1.69

Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study. J Hypertens (2003) 1.69

Does chronic daily headache arise de novo in association with regular use of analgesics? Headache (2003) 1.68